Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

A 2018 update on Hodgkin lymphoma

Posted by on Aug 19, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This review paper analysed the current status of Hodgkin lymphoma research. Following this analysis, guidelines for the diagnosis and treatment of Hodgkin lymphoma were made. Some background Hodgkin lymphoma (HL) is a rare form of cancer which affects B cells (a type of white blood cell). It is necessary to determine which stage of the...

Read More

Investigating bone loss in adult patients with lymphoma or leukemia

Posted by on Aug 18, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the occurrence and impact of bone loss in adult patients with lymphoma and leukemia. This study concluded that these patients have significant bone loss compared to the general population.  Some background Bone loss is a known consequence of many cancers and their treatments. In healthy adults, bone loss is...

Read More

An investigation into the effects of Hodgkin lymphoma on cognition

Posted by on Aug 17, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the effects of chemotherapy on cancer-related cognitive impairment in patients with Hodgkin lymphoma. The main finding was that patients with Hodgkin lymphoma who have been treated with chemotherapy experienced more cognitive decline than individuals without. Some background Chemotherapy is commonly used to treat...

Read More

Reviewing treatment options for very high-risk HL

Posted by on Jul 15, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviewed the treatment options for patients with very high-risk Hodgkin’s lymphoma (HL). Some background Although aggressive lymphomas are sensitive to chemotherapy, many patients do not respond well to first-line treatment. Many patients with Hodgkin’s lymphoma may develop disease progression or relapse after...

Read More

Reviewing treatment options for very high-risk HL

Posted by on Jul 15, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviewed the treatment options for patients with very high-risk Hodgkin’s lymphoma (HL). Some background Although aggressive lymphomas are sensitive to chemotherapy, many patients do not respond well to first-line treatment. Many patients with Hodgkin’s lymphoma may develop disease progression or relapse after...

Read More

Brentuximab vedotin: a study of its safety for unresponsive Hodgkin lymphoma.

Posted by on Jul 3, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to analyse the side effects associated with brentuximab vedotin (BV; Adcetris) treatment for patients with Hodgkin lymphoma (HL) who had undergone stem cell transplantation (SCT) that is now unresponsive to treatment. The main side effects identified included nerve damage, infections and low white blood cell...

Read More

Does anti-PD1 therapy change the effectiveness of chemotherapy in unresponsive Hodgkin lymphoma?

Posted by on Jun 28, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the effects of chemotherapy alone or chemotherapy plus anti-PD1 therapy in patients with relapsing/refractory (RR) Hodgkin's Lymphoma. The main finding was that anti-PD1 treatment enhances the effectiveness of chemotherapy in these patients. Some background Stem cell transplant (SCT) and...

Read More

How accurate is PET/CT in identifying bone marrow involvement in children with Hodgkin lymphoma?

Posted by on Jun 28, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the accuracy of positron emission tomography/computed tomography (PET/CT) scanning and bone marrow biopsy (BMB) to assess bone marrow involvement (BMI) in children with newly diagnosed Hodgkin lymphoma. The main finding was that PET/CT was effective in determining BMI and biopsy should only be...

Read More

What are the effects of different doses and treatments for limited stage classical Hodgkin’s lymphoma?

Posted by on Jun 24, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the effects of increasing the initial dose of chemotherapy in patients with classical Hodgkin’s lymphoma (cHL). The main finding was that it is necessary to assess each treatment plan based on the patient’s individual disease. Some background Chemotherapy plus stem cell transplant (SCT;...

Read More